While prevention through vaccination and biosecurity is the priority in the fight against foot and mouth disease (FMD), complimentary and non-competitive treatment through Tri-Solfen® motivates farmers to resolve pain and heal wounds. The Tri-Solfen® topical analgesia wound formulation is now commonly used in In Australia where its uses include applying Tri-Solfen® for mulesing procedures (80% of Australian farmers use Tri-Solfen® for this). In total 100 million animals have been treated so far.
The first, and currently the only, company globally to develop, launch and commercialise a topical pain and wound management product for use in livestock undergoing painful husbandry procedures – Tri-Solfen® is recognised as the only safe, practical and efficient product for use on such wounds.